Shattuck Labs, Inc.
STTK
Rank in Stocks
#12079
Shattuck Labs, Inc. operates as a biotechnology firm based in the United... Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
Share Price
$4.99
Last synced: 2026-11-09
Market Cap
$500.81M
Change (1 day)
8.01%
Change (1 year)
152.02%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Shattuck Labs, Inc. (STTK)
Category
Healthcare
Operating Margin for Shattuck Labs, Inc. (STTK)
Operating Margin as of November 2026 TTM: -5,578.70%
According to Shattuck Labs, Inc.'s latest financial reports, its current operating margin (TTM) is -5,578.70%. At the end of 2025 the company had an operating margin of -5,150.80%.
Operating Margin history for Shattuck Labs, Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -5,578.70% | 8.31% |
| 2025 | -5,150.80% | 265.75% |
| 2024 | -1,408.27% | -74.62% |
| 2023 | -5,549.61% | -64.98% |
| 2022 | -15,848.01% | 10,408.59% |
| 2021 | -150.81% | -59.43% |
| 2020 | -371.76% | 46.63% |
| 2019 | -253.53% | 825.29% |
| 2018 | -27.40% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.01% |
US
|
|
| -149.01% | -99.97% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.01% |
BE
|
|
| 29.35% | -100.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Shattuck Labs, Inc.'s operating margin
What is Shattuck Labs, Inc.'s operating margin?
Shattuck Labs, Inc.'s operating margin is -5,578.70%, as of Nov 2026.
What was Shattuck Labs, Inc.'s operating margin in 2025?
In 2025, Shattuck Labs, Inc.'s operating margin was -5,150.80%, compared with -1,408.27% in 2024.
How has Shattuck Labs, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Shattuck Labs, Inc.'s operating margin was highest in 2021 (-150.81%) and lowest in 2022 (-15,848.01%).
How does Shattuck Labs, Inc.'s operating margin compare with similar companies?
Shattuck Labs, Inc.'s operating margin (-5,578.70%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.